IP Library Granted Patent US 8,975,255
Granted Patent B2
US 8,975,255 · App. 13/571,158 · Granted Mar 10, 2015

Preparation and pharmaceuticals of biphenyl benzamide-derived derivatives

Inventors: Deh-Ming Chang (Taipei, TW); Hsu-Shan Huang (Taipei, TW); Chia-Chung Lee (Taipei, TW); Chun-Liang Chen (Taipei, TW)
Assignee: National Defense Medical Center
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,975,255
App. No.
13/571,158
Granted
Mar 10, 2015
Kind
B2
Abstract

The present invention provides a biphenyl benzamide-derived derivatives, which structure is selected from formula I or formula II: and the synthesis and the application thereof.

Claims (12)

1. A biphenyl benzamide-derived derivatives, which structure is selected from formula II:

wherein said R 1 , R 2 , R 3 and R 4 of the formula II is selected from the group consisting of H, halogen, CF 3 , CN, CH and OCH 3 .

2. A pharmaceutical composition of biphenyl benzamide-derived derivatives, which comprises:

(a) a structure is selected from formula II:

(b) a pharmaceutical acceptable salt and carrier of the biphenyl benzamide-derived derivatives,

wherein said R 1 , R 2 , R 3 and R 4 of the formula II is selected from the group consisting of H, halogen, CF 3 , CN, CH and OCH 3 .

3. The pharmaceutical composition of claim 2 , wherein the pharmaceutical acceptable carrier is excipient, diluents, thickeners, filler, binder, disintegrants, lubricant, oil or non-oil base, surfactant, suspending agent, gelling agent, adjuvant, anti-corrosive agent, anti-oxidant, stabilizer, coloring agent or flavor.

4. The pharmaceutical composition of claim 2 , wherein the salt is physiological acceptable salt of inorganic acid, inorganic base, organic acid or organic base.

5. The pharmaceutical composition of claim 2 , wherein said composition is powder, granule, liquid, gel or cream.

6. The pharmaceutical composition of claim 2 , wherein said composition is administrated through oral, transdermal, injection, or inhalational manner.

7. A method for synthesis of benzamide-derived derivatives, wherein a compound of formula II is synthesized by compound of formula I:

8. The method of claim 7 , wherein the compound of formula II is synthesized by compound of formula I, tetrahydrofuran/pyridine and methyl chloroformate.

Assignments (2)
CHANGE OF NAME Recorded Dec 9, 2025
From: NATIONAL DEFENSE MEDICAL CENTER
To: NATIONAL DEFENSE MEDICAL UNIVERSITY
Reel/Frame 073166/0560 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2012
From: CHANG, DEH-MING; HUNAG, HSU-SHAN; LEE, CHIA-CHUNG; CHEN, CHUN-LIANG
To: NATIONAL DEFENSE MEDICAL CENTER
Reel/Frame 028777/0424 →
Priority Claims (1)
TW 101113752 A · Apr 18, 2012 · national
Continuity (1)
Related Publication 20130281444A1 · Oct 24, 2013